Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00504205
What this trial is testing

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Astex Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477366
What this trial is testing

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-Cell Non-Hodgkin Lymphoma
ImmunityBio, Inc. 20
Very early researchStudy completedNCT01959477
What this trial is testing

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+142 more
Case Comprehensive Cancer Center 33
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03628612
What this trial is testing

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Who this might be right for
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell TherapyMultiple MyelomaDLBCL+2 more
Autolus Limited 500
Testing effectiveness (Phase 2)UnknownNCT03629873
What this trial is testing

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Who this might be right for
Lymphoma, Large B-Cell, DiffuseMantle Cell LymphomaPeripheral T Cell Lymphoma+1 more
The First Affiliated Hospital with Nanjing Medical University 69
Large-scale testing (Phase 3)Looking for participantsNCT06522737
What this trial is testing

Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Who this might be right for
Lymphoma
SecuraBio 124
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT06323525
What this trial is testing

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Chinese PLA General Hospital 30
Early research (Phase 1)UnknownNCT04594135
What this trial is testing

Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin Lymphoma
iCell Gene Therapeutics 20
Very early researchUnknownNCT04412174
What this trial is testing

GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Hebei Yanda Ludaopei Hospital 18
Not applicableUnknownNCT05814718
What this trial is testing

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Who this might be right for
Autologous Stem Cell TransplantationConditioning
First Affiliated Hospital Xi'an Jiaotong University 122
Early research (Phase 1)Study completedNCT01943682
What this trial is testing

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more
Children's Hospital Medical Center, Cincinnati 27
Very early researchNot Yet RecruitingNCT05728879
What this trial is testing

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

Who this might be right for
Cutaneous T Cell Lymphoma
Northwestern University 30
Testing effectiveness (Phase 2)UnknownNCT02918747
What this trial is testing

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma
Hunan Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Early research (Phase 1)Active Not RecruitingNCT00586391
What this trial is testing

CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL

Who this might be right for
B Cell LymphomaChronic Lymphocytic LeukemiaAcute Lymphocytic Leukemia
Baylor College of Medicine 14
Early research (Phase 1)Looking for participantsNCT06180174
What this trial is testing

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
B Cell LymphomaNon Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT05466318
What this trial is testing

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell
Sichuan University 306
Next Page